解剖病理学市场规模、份额和成长分析（按产品/服务、应用、最终用途和地区划分）—产业预测（2026-2033 年）

全球解剖病理学市场规模预计在 2024 年达到 404.6 亿美元，从 2025 年的 434.2 亿美元增长到 2033 年的 762.9 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.3%。

全球解剖病理市场预计将迎来显着成长，这主要得益于临床生物标记在分子层面上对疾病的深入了解，以及临床决策和患者预后的改善。基于生物标记的病理检测在恶性肿瘤和新生物的诊断中的日益普及，进一步推动了这一市场需求。此外，数位显微镜和染色系统等先进技术在病理仪器中的应用，尤其是在印度和中国等新兴市场，预计将进一步促进市场扩张。主要企业正积极研发创新病理仪器，并透过合作推出尖端产品，提升自身价值。这种领导企业间的合作环境可望加速解剖病理领域中新型解决方案的采纳与应用，进而推动整体市场成长。

解剖病理学市场驱动因素

由于慢性病盛行率不断上升，以及消费者生活方式和饮食习惯的改变，解剖病理学市场预计将迎来显着增长。老年人口，尤其是65岁及以上人群，正在迅速增长，推动了对关键诊断服务的需求，以应对与老龄化相关的健康问题。随着医疗保健系统调整以提供更全面的诊断解决方案，这种人口结构的变化可能会推动组织病理学的发展。此外，大众对慢性病的认识不断提高，促使人们更加重视早期发现和准确诊断，从而提升了市场的整体成长潜力。

解剖病理学市场限制因素

全球翻新解剖病理设备供应有限，对解剖病理市场的成长构成重大挑战。许多终端用户，尤其是中小型医院和检查室，优先考虑成本效益高的解决方案，因此往往选择翻新设备。然而，翻新设备的短缺限制了这些机构的取得途径和经济承受能力，从而构成了一大障碍。因此，翻新设备的供不应求预计将阻碍解剖病理市场的扩张和发展，影响医疗机构满足诊断需求的能力。

解剖病理学市场趋势

解剖病理市场正经历显着成长，这主要得益于数位显微镜、染色系统和宏观成像技术等先进病理设备的日益普及。与传统方法相比，这些创新提高了诊断的准确性和特异性，从而促进了其在实验室中的广泛应用。此外，这些先进仪器的操作简单性也提高了病理学家和技术人员的参与度。随着医疗机构日益重视诊断的准确性和效率，解剖病理市场预计将大幅扩张，这反映了医疗保健行业现代化和技术进步的整体趋势。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 生态系测绘
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 技术评估
• 监管环境
• 管道分析
• 疾病流行病学
• 专利分析

全球解剖病理学市场规模（按产品和服务划分），复合年增长率（2026-2033 年）

• 装置
  • 玻片染色系统
  • 组织处理系统
  • 细胞处理设备
  • 切片机/冰冻切片机
  • 嵌入式系统
  • 玻璃鞋套
  • 其他产品
• 消耗品
  • 抗体
  • 一抗
  • 二抗
  • 试剂盒和试剂
  • 染色剂和溶剂
  • 固定剂
  • 其他试剂盒和试剂
  • 探测
  • 其他消耗品
• 服务
  • 组织病理学服务
  • 细胞病理服务

全球解剖病理学市场规模（按应用领域划分），复合年增长率（2026-2033 年）

• 疾病诊断
  • 癌症
  • 乳癌
  • 消化系统癌症
  • 肺癌
  • 摄护腺癌
  • 其他癌症
  • 其他疾病
• 医学研究
• 药物发现与开发
• 其他的

全球解剖病理学市场规模（按最终用途划分）、复合年增长率（2026-2033 年）

• 医院
• 临床检查室
• 诊断检查室
• 其他的

全球解剖病理学市场规模、复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• F. Hoffman-LA Roche Ltd.
• Danaher Corporation
• PHC Holdings Corporation
• Abcam Plc.
• Hologic, Inc.
• Agilent Technologies
• Becton, Dickinson And Company
• Sakura Finetek Usa Inc.
• Merck Kgaa
• Bio SB
• Quest Diagnostics Incorporated
• Laboratory Corporation of America Holdings
• Cardinal Health
• NeoGenomics Laboratories, Inc.
• BioGenex
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Siemens AG
• Cell Signaling Technology, Inc.
• PerkinElmer Inc.

结论与建议

Anatomic Pathology Market size was valued at USD 40.46 Billion in 2024 and is poised to grow from USD 43.42 Billion in 2025 to USD 76.29 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The global anatomic pathology market is poised for significant growth, driven by the increasing utilization of clinical biomarkers that enhance disease understanding at a molecular level, thus improving clinical decision-making and patient outcomes. The growing prevalence of biomarker-based pathology tests aimed at malignancy and tumorigenesis further supports this demand. Additionally, the integration of advanced technologies in pathology equipment-such as digital microscopes and staining systems-especially in emerging markets like India and China, is anticipated to bolster market expansion. Key industry players are actively developing innovative pathology devices and fostering collaborations to introduce cutting-edge products, enhancing their offerings. This collaborative environment among major companies is expected to accelerate the adoption and implementation of novel solutions in anatomic pathology, fueling overall market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Anatomic Pathology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Anatomic Pathology Market Segments Analysis

Global Anatomic Pathology Market is segmented by product, application, end use and region. Based on product, the market is segmented into instruments, consumables and services. Based on application, the market is segmented into disease diagnostics, medical research, drug discovery and development and others. Based on end use, the market is segmented into hospitals, clinical laboratories, diagnostic laboratories and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Anatomic Pathology Market

The anatomic pathology market is anticipated to experience substantial growth due to the rising prevalence of chronic diseases alongside evolving consumer lifestyles and dietary habits. The aging population, particularly individuals aged 65 and older, is rapidly increasing, creating a heightened demand for diagnostic services integral to addressing age-related health concerns. This demographic shift is likely to fuel advancements in anatomic pathology, as healthcare systems adapt to provide more comprehensive diagnostic solutions. Furthermore, as public awareness of chronic conditions grows, the market will benefit from an increased focus on early detection and accurate diagnosis, enhancing its overall growth potential.

Restraints in the Anatomic Pathology Market

The limited availability of refurbished anatomic pathology equipment globally poses a significant challenge to the growth of the anatomic pathology market. Many end users, particularly small and medium-sized hospitals and laboratories, prioritize cost-effective solutions and often opt for refurbished equipment. This preference creates a substantial barrier, as the scarcity of such equipment restricts access and affordability for these institutions. Consequently, the insufficient supply of refurbished tools is anticipated to hinder the expansion and development of the anatomic pathology market, impacting the ability of healthcare providers to equip themselves adequately for diagnostic needs.

Market Trends of the Anatomic Pathology Market

The Anatomic Pathology market is experiencing significant growth, driven by the rising adoption of advanced pathology equipment such as digital microscopes, staining systems, and gross imaging technologies. These innovations enhance diagnostic accuracy and specificity compared to traditional methods, propelling their widespread integration within laboratories. Additionally, the user-friendly nature of these advanced devices is fostering increased engagement among pathologists and laboratory technicians. As healthcare institutions prioritize precision and efficiency in diagnostics, the Anatomic Pathology market is poised for substantial expansion, reflecting a broader trend towards modernization and technological advancement within the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree Of Competition
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• Pestel Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape
• Pipeline Analysis
• Disease Epidemiology
• Patent Analysis

Global Anatomic Pathology Market Size by Product & Services & CAGR (2026-2033)

• Market Overview
• Instruments
  • Slide Staining Systems
  • Tissue Processing Systems
  • Cell Processors
  • Microtomes & Cryostat
  • Embedding Systems
  • Cover Slippers
  • Other Products
• Consumables
  • Antibodies
  • Primary Antibodies
  • Secondary Antibodies
  • Kits And Reagents
  • Stains And Solvents
  • Fixatives
  • Other Kits and Reagents
  • Probes
  • Other Consumables
• Services
  • Histopathology Services
  • Cytopathology Services

Global Anatomic Pathology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Disease Diagnostics
  • Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancers
  • Other Diseases
• Medical Research
• Drug Discovery and Development
• Others

Global Anatomic Pathology Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinical Laboratories
• Diagnostic Laboratories
• Others

Global Anatomic Pathology Market Size & CAGR (2026-2033)

• North America (Product & Services, Application, End Use)
  • US
  • Canada
• Europe (Product & Services, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffman-LA Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PHC Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam Plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson And Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek Usa Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Kgaa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio SB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations